Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer H Martin

Showing results (11-20 of 184) with videos related to

Pageof 19
Sort By:
The Medical Journal of Australia|April 13, 2021
Lack of efficacy of cannabidiol for relieving back pain: time to re-set expectations?Chris Hayes, Jennifer H Martin
The Medical Journal of Australia|November 5, 2016
Medicinal cannabis in Australia: the missing linksJennifer H Martin, Yvonne Bonomo
Clinical Science (London, England : 1979)|June 30, 2007
Statins and clinical outcomes in heart failureJennifer H Martin, Henry Krum
British Journal of Clinical Pharmacology|January 21, 2015
From an evolutionary perspective, all 'new' antimicrobial targets are old: time to think outside the boxJennifer H Martin, Albert Ferro
British Journal of Clinical Pharmacology|August 24, 2018
Care and concern with cannabinoids used therapeuticallyJennifer H Martin, Noel Cranswick
Internal Medicine Journal|April 10, 2020
College conferences: time for merit-based selection of speakers and educators?Jennifer H Martin, Nikola A Bowden
Journal of the American College of Cardiology|September 7, 2019
Clinically Optimal Versus "Target" Doses in Heart FailureSimon B Dimmitt, Jennifer H Martin
British Journal of Clinical Pharmacology|April 14, 2019
Cannabinoid use in practice in Australasia-Better guidance and new drug information systems will be essential for prescribersJennifer H Martin, Nicholas J Talley
The British Journal of Nutrition|June 3, 2021
Obesity and COVID-19: renin-angiotensin as a mediator of morbidity and mortalityJennifer H Martin, Richard E Head
Journal of Clinical Pharmacology|September 19, 2017
Pharmacokinetic-Guided Dosing of New Oral Cancer AgentsCatherine J Lucas, Jennifer H Martin
Pageof 19

Showing results (11-20 of 184) with videos related to

Sort By:
Pageof 19
The Medical Journal of Australia|April 13, 2021
Lack of efficacy of cannabidiol for relieving back pain: time to re-set expectations?Chris Hayes, Jennifer H Martin
The Medical Journal of Australia|November 5, 2016
Medicinal cannabis in Australia: the missing linksJennifer H Martin, Yvonne Bonomo
Clinical Science (London, England : 1979)|June 30, 2007
Statins and clinical outcomes in heart failureJennifer H Martin, Henry Krum
British Journal of Clinical Pharmacology|January 21, 2015
From an evolutionary perspective, all 'new' antimicrobial targets are old: time to think outside the boxJennifer H Martin, Albert Ferro
British Journal of Clinical Pharmacology|August 24, 2018
Care and concern with cannabinoids used therapeuticallyJennifer H Martin, Noel Cranswick
Internal Medicine Journal|April 10, 2020
College conferences: time for merit-based selection of speakers and educators?Jennifer H Martin, Nikola A Bowden
Journal of the American College of Cardiology|September 7, 2019
Clinically Optimal Versus "Target" Doses in Heart FailureSimon B Dimmitt, Jennifer H Martin
British Journal of Clinical Pharmacology|April 14, 2019
Cannabinoid use in practice in Australasia-Better guidance and new drug information systems will be essential for prescribersJennifer H Martin, Nicholas J Talley
The British Journal of Nutrition|June 3, 2021
Obesity and COVID-19: renin-angiotensin as a mediator of morbidity and mortalityJennifer H Martin, Richard E Head
Journal of Clinical Pharmacology|September 19, 2017
Pharmacokinetic-Guided Dosing of New Oral Cancer AgentsCatherine J Lucas, Jennifer H Martin
Pageof 19